Vicks NyQuil
- Product NDC
- 37000-808
- Requested package NDC
- 37000-808-06
- 11-digit product format
- 370000808
- Labeler code
- 37000
- Product ID
- 37000-808_f173dffb-ad32-0665-e053-2995a90a72f6
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- The Procter & Gamble Manufacturing Company
- Application
- M012
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2010-06-01
- Marketing end
- 0000-00-00
- Substance
- ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE
- Active strength
- 650 mg/30mL; mg/30mL; mg/30mL
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 37000-808 | 37000-808-06 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 37000-808-08 | 2023-01-04 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-12 | 2023-01-04 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-24 | 2023-01-04 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-36 | 2023-01-04 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-08 | 2022-07-29 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-12 | 2022-07-29 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-24 | 2022-07-29 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-36 | 2022-07-29 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-08 | 2021-02-11 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-12 | 2021-02-11 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-24 | 2021-02-11 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-36 | 2021-02-11 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-08 | 2021-01-29 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-12 | 2021-01-29 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-24 | 2021-01-29 | VICKS ® NyQuil ® COLD & FLU |
| 37000-808-36 | 2021-01-29 | VICKS ® NyQuil ® COLD & FLU |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 37000-808-08 | ML - Milliliter | 37000-808 | 7863091a-9378-4c61-84c7-ea7246ab0a20 | 1 | 2013-06-04 |
| 37000-808-12 | ML - Milliliter | 37000-808 | fbc01624-d64c-49ed-944e-d4b2a1d66d07 | 1 | 2013-06-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Family Wellness Oxymetazoline No Drip | OXYMETAZOLINE | FAMILY DOLLAR (Family Wellness) | 0c006b1c-8ab2-4b9c-8738-e7001c1bb47d | 2026-10-26 | Warnings | M012 |
| Family Wellness Oxymetazoline Sinus Severe | OXYMETAZOLINE | FAMILY DOLLAR (Family Wellness) | 13237d31-c60a-49f8-9b96-4414cf766a08 | 2026-10-26 | Warnings | M012 |
| HISTEX-DM New Formulation | DEXTROMETHORPHAN HBR, PSEUDOEPHEDRINE HCI, AND TRIPROLIDINE HCI | Allegis Pharmaceuticals, LLC | 30010401-e5b4-2bd9-e063-6394a90a0b0b | 2026-10-26 | Warnings | M012 |
| HISTEX-DM | DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | 836d062c-29f0-4fd7-b65c-771a3bbd52c4 | 2026-10-26 | Warnings | M012 |
| HISTEX | TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | cc466d33-cf3e-4f1c-a794-6d3d79903adf | 2026-10-26 | Warnings | M012 |
| HISTEX PD Drops New Formulation | TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | 0c693f15-5d76-3dbf-e063-6294a90af9ac | 2026-10-26 | Warnings | M012 |
| Guaifenesin 400mg | GUAIFENESIN | Marlex Pharmaceuticals Inc | 13f4db4e-687e-9d7b-e063-6294a90ab088 | 2026-10-26 | Warnings | M012 |
| Guaifenesin 200mg | GUAIFENESIN | Marlex Pharmaceuticals Inc | 13b8f480-d1ac-d70c-e063-6394a90ab4f4 | 2026-10-26 | Warnings | M012 |
| NASAL and SINUS DECONGESTANT | PHENYLEPHRINE HYDROCHLORIDE | JHK Inc dba American Safety & First Aid | 63e51305-2575-49c4-9fda-7b3e1b4b6ede | 2026-10-26 | Warnings | M012 |
| MUCINEX FAST-MAX NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 3a24b06c-00a6-c2ef-e063-6294a90a4d72 | 2026-10-25 | Warnings | M012 |
| Mucinex Nightshift Cold and Flu Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 316b5569-b66f-f30c-e063-6394a90ae147 | 2026-10-25 | Warnings | M012 |
| Mucinex Fast-Max Kickstart Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | fda745ca-b486-47ca-e053-6394a90a87c3 | 2026-10-24 | Warnings | M012 |
| Mucinex Fast-Max Kickstart Severe Congestion and Cough and Mucinex Fast-Max Nighttime Cold and Flu | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, ACETAMINOPHEN,TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 34fd2458-9acd-cdf7-e063-6394a90a3d0a | 2026-10-24 | Warnings | M012 |
| DAYTIME NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Amazon.com Services LLC | e1b2d448-f84f-49ec-821c-ad03c4c6a59a | 2026-10-23 | Warnings | M012 |
| Mucinex Fast-Max Kickstart Severe Congestion and Cough Maximum Strength | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Reckitt Benckiser LLC | 19105007-0193-0764-e063-6294a90a01a4 | 2026-10-23 | Warnings | M012 |
| Publix Maximum Strength | OXYMETAZOLINE HYDROCHLORIDE | PUBLIX SUPER MARKETS, INC | cf49a06d-f095-48bf-bcd2-a410066ff9af | 2026-10-22 | Warnings | M012 |
| Publix | OXYMETAZOLINE HYDROCHLORIDE | PUBLIX SUPER MARKETS, INC | 283e42b9-173c-4deb-9377-ff649efc177f | 2026-10-22 | Warnings | M012 |
| CHILDRENS ALLERGY RELIEF | DIPHENHYDRAMINE HCL | Amazon.com Services LLC | c10709ea-7c49-44f6-abde-330c09ee960b | 2026-10-22 | Warnings | M012 |
| Mucus Relief DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Chain Drug Marketing Association, Inc. | d02f32c1-716e-4753-abba-ff97c4dc9e22 | 2026-10-22 | Warnings | M012 |
| Tylenol Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | 7a60184f-91a9-4b85-b243-871deca63450 | 2026-10-22 | Warnings | M012 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 37000-808-06 | 37000080806 | 177 mL in 1 BOTTLE, PLASTIC (37000-808-06) | 177 ml | 2021-07-13 | 0000-00-00 | No | No | Current |